Liver Vessel Enhancement by Gd-BOPTA and Gd-EOB-DTPA: A Comparison in Healthy Volunteers

被引:75
|
作者
Brismar, T. B. [1 ]
Dahlstrom, N. [2 ,3 ]
Edsborg, N.
Persson, A. [3 ]
Smedby, O. [3 ,4 ]
Albiin, N.
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Radiol, SE-14186 Stockholm, Sweden
[2] Hudiksvall Hosp, Dept Radiol, Hudiksvall, Sweden
[3] Linkoping Univ, Ctr Med Image Sci & Visualizat, Linkoping, Sweden
[4] Linkoping Univ, Dept Radiol IMH, Linkoping, Sweden
关键词
Contrast dynamics; Gd-BOPTA; Gd-EOB-DTPA; liver; MRI; GADOBENATE DIMEGLUMINE; CLINICAL-EVALUATION; CONTRAST AGENTS; PHARMACOKINETICS; SAFETY; MRI;
D O I
10.1080/02841850903055603
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: A thorough understanding of magnetic resonance (MR) contrast media dynamics makes it possible to choose the optimal contrast media for each investigation. Differences in visualizing hepatobiliary function between Gd-BOPTA and Gd-EOB-DTPA have previously been demonstrated, but less has been published regarding differences in liver vessel visualization. Purpose: To compare the liver vessel and liver parenchymal enhancement dynamics of Gd-BOPTA (MultiHance) and Gd-EOB-DTPA (Primovist). Material and Methods: The signal intensity of the liver parenchyma, the common hepatic artery, the middle hepatic vein, and a segmental branch of the right portal vein was obtained in 10 healthy volunteers before contrast media administration, during arterial and portal venous phases, and 10, 20, 30, 40, and 130 min after intravenous contrast medium injection, but, due to scanner limitations, not during the hepatic venous phase. The doses of contrast media were 0.1 mmol/kg for Gd-BOPTA and 0.025 mmol/kg for Gd-EOB-DTPA. Results: Maximum enhancement of liver parenchyma was observed from the portal venous phase until 130 min after Gd-BOPTA administration and from 10 min to 40 min after Gd-EOB-DTPA. There was no difference in maximum enhancement of liver parenchyma between the two contrast media. When using Gd-BOPTA, the vascular contrast enhancement was still apparent 40 min after injection, but had vanished 10 min after Gd-EOB-DTPA injection. The maximum difference in signal intensity between the vessels and the liver parenchyma was significantly greater with Gd-BOPTA than with Gd-EOB-DTPA (P<0.0001). Conclusion: At the dosage used in this study, Gd-BOPTA yields higher maximum enhancement of the hepatic artery, portal vein, and middle hepatic vein during the arterial and the portal venous phase and during the delayed phases than Gd-EOB-DTPA does, whereas there is no difference in liver parenchymal enhancement between the two contrast agents.
引用
收藏
页码:709 / 715
页数:7
相关论文
共 50 条
  • [11] Liver tumors: Comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA
    Vogl, TJ
    Kummel, S
    Hammerstingl, R
    Schellenbeck, M
    Schumacher, G
    Balzer, T
    Schwarz, W
    Muller, PK
    Bechstein, WO
    Mack, MG
    Sollner, O
    Felix, R
    RADIOLOGY, 1996, 200 (01) : 59 - 67
  • [12] COMPARISON OF GD-BOPTA WITH GD-DTPA IN MR IMAGING OF RAT-LIVER
    PAVONE, P
    PATRIZIO, G
    BUONI, C
    TETTAMANTI, E
    PASSARIELLO, R
    MUSU, C
    TIRONE, P
    FELDER, E
    RADIOLOGY, 1990, 176 (01) : 61 - 64
  • [13] Reply to "Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia"
    Reizine, Edouard
    Luciani, Alain
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2020, 52 (04) : 1279 - 1280
  • [14] Lesion detection and assessment of extrahepatic findings in abdominal MRI using hepatocyte specific contrast agents - comparison of Gd-EOB-DTPA and Gd-BOPTA
    Ringe, Kristina I.
    Boll, Daniel T.
    Husarik, Daniela B.
    Bashir, Mustafa R.
    Gupta, Rajan T.
    Merkle, Elmar M.
    BMC MEDICAL IMAGING, 2013, 13
  • [15] Lesion detection and assessment of extrahepatic findings in abdominal MRI using hepatocyte specific contrast agents – comparison of Gd-EOB-DTPA and Gd-BOPTA
    Kristina I Ringe
    Daniel T Boll
    Daniela B Husarik
    Mustafa R Bashir
    Rajan T Gupta
    Elmar M Merkle
    BMC Medical Imaging, 13
  • [16] Functional magnetic resonance cholangiography with Gd-EOB-DTPA: A study in healthy volunteers
    Lee, Seung Wha
    Cha, Sang Hoon
    Chung, Hwan Hoon
    Kim, Kee Hwan
    Yeom, Suk Keu
    Seo, Bo Kyung
    Je, Bo Kyung
    Kim, Baek Hyun
    MAGNETIC RESONANCE IMAGING, 2014, 32 (04) : 385 - 391
  • [17] The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat
    Shuter, B
    Tofts, PS
    Wang, SC
    Pope, JM
    MAGNETIC RESONANCE IMAGING, 1996, 14 (03) : 243 - 253
  • [18] Comparison of Gd-DTPA and Gd-BOPTA for Studying Renal Perfusion and Filtration
    Notohamiprodjo, Mike
    Pedersen, Michael
    Glaser, Christian
    Helck, Andreas D.
    Lodemann, Klaus-Peter
    Jespersen, Bente
    Fischereder, Michael
    Reiser, Maximilian F.
    Sourbron, Steven P.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2011, 34 (03) : 595 - 607
  • [19] Impaired hepatic Gd-EOB-DTPA enhancement after radioembolisation of liver malignancies
    Powerski, Maciej Janusz
    Scheurig-Muenkler, Christian
    Hamm, Bernd
    Gebauer, Bernhard
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2014, 58 (04) : 472 - 480
  • [20] Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?
    Okada, Masahiro
    Ishii, Kazunari
    Numata, Kazushi
    Hyodo, Tomoko
    Kumano, Seishi
    Kitano, Masayuki
    Kudo, Masatoshi
    Murakami, Takamichi
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (03) : 307 - 313